DENTSPLY International designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company was founded in 1899 and is based in York, Pennsylvania.
XRAY Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for XRAY, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that DENTSPLY SIRONA Inc ranked in the 30th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 52%. The most interesting components of our discounted cash flow analysis for DENTSPLY SIRONA Inc ended up being:
As a business, XRAY is generating more cash flow than 71.42% of positive cash flow stocks in the Healthcare.
XRAY's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 36.49% of tickers in our DCF set.
DENTSPLY SIRONA Inc's effective tax rate, as measured by taxes paid relative to net income, is at 29 -- greater than 89.89% of US stocks with positive free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of DENTSPLY SIRONA Inc? See CAH, IONS, PRAH, BIO, and ESMC.
DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (XRAY), the Dental Solutions Company, today announced that it will participate in the Stifel 2020 Jaws and Paws Conference on May 27th. Don Casey, Chief Executive Officer, will represent the company and is scheduled to participate in a fireside chat at 4:45PM Eastern Time. A replay of the presentation will also be available on the Dentsply Sirona website at www.dentsplysirona.com.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc. New York, May 21, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Moody's Investors Service, ("Moody's") today affirmed Dentsply Sirona Inc.'s Baa2 senior unsecured rating, its Baa2 issuer rating and Prime-2 Commercial Paper rating. Moody's also assigned a Baa2 rating to the company's proposed offering of senior unsecured notes.